EURONEXT-BRU$SVYSF
SOLVAY · Q2 2026 earnings
Q2 2026 earnings · · Investor relations
Briefing
Solvay reported Q2 2026 underlying net sales of €1,031 million and underlying EBITDA of €187 million.
Solvay's Q2 2026 results showed underlying net sales of €1,031 million, down 7.4% organically year-over-year due to weak soda ash pricing and impacts from the Middle East conflict. Underlying EBITDA reached €187 million with an 18.1% margin, and underlying net profit from continuing operations was €64 million. The company confirmed its full-year 2026 guidance for underlying EBITDA between €770-850 million and free cash flow of at least €200 million.
- Underlying net sales €1,031 million (-7.4% organic YoY) impacted by soda ash pricing and Middle East conflict effects on operations.
- Underlying EBITDA €187 million (18.1% margin), down 19.5% organically, partly due to prior year one-off and conflict-related shutdowns.
- Underlying net profit from continuing operations €64 million vs. €99 million in Q2 2025.
- Full-year 2026 guidance confirmed: EBITDA €770-850 million and FCF ≥ €200 million, with Saudi peroxides plant restart expected in Q3.
Headline financials
Revenue & EPS history
Solvay · Revenue · Quarterly
€1.17B
Forward guidance
Full-year 2026 guidance confirmed anticipating Saudi peroxides plant restart in Q3.
Tailwinds
- Structural cost savings initiatives delivering €26 million in Q2.
- Approval of €15-20 million strategic investments in rare earths separation at La Rochelle.
- Focus on transformation and safety performance improvements.
Headwinds
- Continued challenging economic environment and weak soda ash pricing.
- Negative impact from Middle East conflict on Peroxides operations.
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro